Database

Startups

Main Industry
Health Care
Main Product/Service
1. Aries E500i
2. InsightEyes EGD
3. InsightEyes EGD Dongle
4. InsightEyes MFN
5. 21.5" LCD Monitor
Founded Year
2015
Unified Business No.
28113954
Status
Active
Number of Employees
0
Total Paid-in Capital
308,311,370 (NT$)
Location of Company
Taiwan , Hsinchu County
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself. Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
About the Company
Insight Medical Solutions developed the world's first magnetically controlled capsule endoscope capable of completely examining the upper digestive tract (EGD).

KLaser group first entered the capsule endoscopy research field through a technology development program with the MOEA in 2003. Active development of Magnetically controlled capsule endoscope prototype since 2013, and to develop the first magnetically controlled capsule endoscope.

Insight Medical Solutions(one of companies in KLaser group) was founded in 2015, completed 10 clinical trials in 2016, obtained investment approval from the National Development Fund in 2018, and launched our product in Taiwan market in 2019.

Our vision is to develop more safety and effectivation medical equipment and to promote social welfare and national health. The InsightEyes EGD System realizes anesthesia-free, painless, disposable and cross infection-free upper gastrointestinal endoscopy with an easy examination process and high patient acceptance. The fear of traditional endoscopic examinations, medical risks of anesthesia and postoperative complications can be avoided. It can provide early diagnosis and early treatment for various common diseases of the esophagus and stomach. In addition, we also provides related medical equipment rental service.



more ↓

Similar Companies

tst biomedical electronics Co., Ltd.

1. iProtin® Surface Acoustic Wave (SAW) Core Technology Platform: iProtin® is a next-generation in vitro diagnostic (IVD) solution developed by tst biomedical electronics Co., Ltd. Utilizing high-frequency reflective shear-horizontal surface acoustic wave (SH-SAW) sensor chips, it can detect real-time changes in mass and viscoelasticity on the sensing surface during antigen-antibody binding. This allows for highly sensitive quantitative or semi-quantitative detection results without the need for enzyme or fluorescent labeling. Benefiting from the unique physical properties of surface acoustic wave technology, the detection process is free from interference by blood cells, allowing the direct use of a 5 μL fingertip whole blood sample to complete high-sensitivity analysis within 3 minutes. This platform technology has obtained patents in multiple countries, features high scalability and a modular design, and can be flexibly applied to the detection of various disease biomarkers, including cardiovascular diseases, inflammatory markers, and cancer-related proteins.

2. Support for Customized Development and OEM/ODM Collaboration Models: tst biomedical electronics Co., Ltd. provides one-stop manufacturing services ranging from wafer fabrication to diagnostic biochips, assisting customers in rapidly achieving commercialization. We possess patented cavity packaging technology, which can effectively protect the surface acoustic wave sensor chip and enhance signal stability and reliability; paired with 10 nL high-precision biomaterial coating technology, it can effectively reduce production costs and facilitate biochip miniaturization. tst biomedical electronics Co., Ltd. supports customized development and OEM/ODM collaboration models, and can design chips, packaging modules, and biocoating solutions according to specific requirements, assisting academic and research institutions, startups, or corporate clients in smoothly transitioning from proof of concept and trial production to mass production.

3. The iProtin® testing platform provides API integration capabilities, which can integrate personal health indices, lifestyle habits, and medication records to achieve companion diagnostics and personalized health management. Through connections with wearable devices, health cloud platforms, or electronic medical record (EMR) systems, users can adjust exercise intensity, dietary intake, or medication dosage in real time based on test results, visualizing health data and truly implementing proactive and precise health management.
(The content above was translated by AI.)
回頁面最頂端